The obesogenic effects of polyunsaturated fatty acids are dependent ...

54. Xu, J. et al. Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression
by accelerating transcript decay. The Journal of biological chemistry 276, 9800-7(2001).
55. Takeuchi, Y. et al. Polyunsaturated fatty acids selectively suppress sterol regulatory element-binding protein-1
through proteolytic processing and autoloop regulatory circuit. The Journal of biological chemistry 285, 11681-
91(2010).
56. Ou, J. et al. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c
(SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proceedings of the National
Academy of Sciences of the United States of America 98, 6027-32(2001).
57. Horton, J.D., Goldstein, J.L. & Brown, M.S. SREBPs: activators of the complete program of cholesterol and
fatty acid synthesis in the liver. The Journal of clinical investigation 109, 1125-31(2002).
58. Matsuzaka, T. et al. Insulin-Independent Induction of Sterol Regulatory Element-Binding Protein-1c Expression
in the Livers of Streptozotocin-Treated Mice. Diabetes 53, 560-569(2004).
59. Kawaguchi, T. et al. Glucose and cAMP regulate the L-type pyruvate kinase gene by
phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proceedings of the
National Academy of Sciences of the United States of America 98, 13710-5(2001).
60. Dentin, R. et al. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of
ChREBP nuclear protein translocation. The Journal of clinical investigation 115, 2843-54(2005).
61. Mitro, N. et al. The nuclear receptor LXR is a glucose sensor. Nature 445, 219-23(2007).
62. Denechaud, P.-D. et al. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in
mouse liver. The Journal of clinical investigation 118, 956-64(2008).
63. Lazar, M.A. & Willson, T.M. Sweet dreams for LXR. Cell metabolism 5, 159-61(2007).
64. Anthonisen, E.H. et al. Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. The
Journal of biological chemistry 285, 1607-15(2010).
65. Porstmann, T. et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth.
Cell metabolism 8, 224-36(2008).
66. Li, S., Brown, M.S. & Goldstein, J.L. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required
for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proceedings of the National Academy of
Sciences of the United States of America 107, 3441-6(2010).
67. Kawaguchi, T. et al. Mechanism for fatty acid “sparing” effect on glucose-induced transcription: regulation of
carbohydrate-responsive element-binding protein by AMP-activated protein kinase. The Journal of biological
chemistry 277, 3829-35(2002).
68. Li, Y. et al. AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and
Atherosclerosis in Diet-Induced Insulin-Resistant Mice. Cell metabolism 13, 376-88(2011).
69. Basciano, H., Federico, L. & Adeli, K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition &
metabolism 2, 5(2005).
70. Tappy, L. & Lê, K.-A. Metabolic effects of fructose and the worldwide increase in obesity. Physiological
reviews 90, 23-46(2010).
19